OTCMKTS:TXSP - Taxus Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.17 +0.01 (+0.32 %) (As of 01/22/2019 01:22 PM ET)Previous Close$3.16Today's Range$3.17 - $3.1752-Week Range$3.16 - $3.16Volume100 shsAverage VolumeN/AMarket Capitalization$258.36 millionP/E RatioN/ADividend YieldN/ABeta-0.19 ProfileDiscussionChartFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Taxus Pharmaceuticals Holdings, Inc. manages and operates health and wellness stores. Its products include dietary supplements, vitamins, minerals, calcium, fibers, proteins and sport nutrition items. The company was founded on January 2, 2002 and is headquartered in Little Neck, NY. Receive TXSP News and Ratings via Email Sign-up to receive the latest news and ratings for TXSP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug stores & proprietary stores Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TXSP Previous Symbol CUSIPN/A WebN/A Phone718-631-1522Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$10,000.00 Price / Sales25,835.50 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares81,500,000Market Cap$258.36 million OptionableNot Optionable Taxus Pharmaceuticals (OTCMKTS:TXSP) Frequently Asked Questions What is Taxus Pharmaceuticals' stock symbol? Taxus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "TXSP." When is Taxus Pharmaceuticals' next earnings date? Taxus Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Friday, April 19th 2019. View Earnings Estimates for Taxus Pharmaceuticals. Has Taxus Pharmaceuticals been receiving favorable news coverage? News coverage about TXSP stock has been trending very positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Taxus Pharmaceuticals earned a news impact score of 3.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days. Who are some of Taxus Pharmaceuticals' key competitors? Some companies that are related to Taxus Pharmaceuticals include Diplomat Pharmacy (DPLO), 111 (YI), Petmed Express (PETS), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP). Who are Taxus Pharmaceuticals' key executives? Taxus Pharmaceuticals' management team includes the folowing people: Jia Yue Zhang, Chairman, President, Chief Executive Officer & CFO How do I buy shares of Taxus Pharmaceuticals? Shares of TXSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Taxus Pharmaceuticals' stock price today? One share of TXSP stock can currently be purchased for approximately $3.17. How big of a company is Taxus Pharmaceuticals? Taxus Pharmaceuticals has a market capitalization of $258.36 million and generates $10,000.00 in revenue each year. How can I contact Taxus Pharmaceuticals? Taxus Pharmaceuticals' mailing address is 23605 BRADDOCK AVENUE, BELLEROSE NY, 11426. The company can be reached via phone at 718-631-1522. MarketBeat Community Rating for Taxus Pharmaceuticals (OTCMKTS TXSP)Community Ranking: 1.9 out of 5 ()Outperform Votes: 74 (Vote Outperform)Underperform Votes: 118 (Vote Underperform)Total Votes: 192MarketBeat's community ratings are surveys of what our community members think about Taxus Pharmaceuticals and other stocks. Vote "Outperform" if you believe TXSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TXSP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: What is cost of equity?